Dr Mishal Shoaib Khan, MD | |
27 Hospital Avenue, Suite 303, Danbury, CT 06810 | |
(203) 798-0500 | |
(203) 798-0881 |
Full Name | Dr Mishal Shoaib Khan |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 20 Years |
Location | 27 Hospital Avenue, Danbury, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609059732 | NPI | - | NPPES |
008032077 | Medicaid | CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 048631 (Connecticut) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Women's Health Associates, P.c. | 8224000229 | 4 |
News Archive
Guidant Corporation has announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) will review Guidant's submission to expand user labeling, including indications, for its cardiac resynchronization therapy defibrillators
Developing psychiatric medications is a long and complex process. Candidate drugs are evaluated and assessed based on their effects on the behavior of animals, usually rats or mice. Each class of drugs, from antidepressants to antipsychotics, is tested differently - often in a labor-intensive process that leaves plenty of room for human error. And there is a growing consensus that current procedures fail to effectively produce new medications.
Nipro Diagnostics, Inc. today announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalance and TRUEtrack Blood Glucose Meters distributed both in the United States and outside the United States.
Two manufacturing facilities of Glenmark located in Goa and Nashik bagged the prestigious 'Greentech Environment Gold Award - 2015' for Excellence in Environment Management at a ceremony in Kolkata recently. Greentech Environment Awards are presented ever year to companies/units in India demonstrating the highest level of commitment to Environmental Management across different sectors.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amgen/Pfizer's Enbrel is the leading tumor necrosis factor -alpha inhibitor prescribed in newly diagnosed rheumatoid arthritis patients, outpacing Abbott's Humira in the first three lines of treatment.
› Verified 2 days ago
Entity Name | Nuvance Health Medical Practice Ct Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
Guidant Corporation has announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) will review Guidant's submission to expand user labeling, including indications, for its cardiac resynchronization therapy defibrillators
Developing psychiatric medications is a long and complex process. Candidate drugs are evaluated and assessed based on their effects on the behavior of animals, usually rats or mice. Each class of drugs, from antidepressants to antipsychotics, is tested differently - often in a labor-intensive process that leaves plenty of room for human error. And there is a growing consensus that current procedures fail to effectively produce new medications.
Nipro Diagnostics, Inc. today announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalance and TRUEtrack Blood Glucose Meters distributed both in the United States and outside the United States.
Two manufacturing facilities of Glenmark located in Goa and Nashik bagged the prestigious 'Greentech Environment Gold Award - 2015' for Excellence in Environment Management at a ceremony in Kolkata recently. Greentech Environment Awards are presented ever year to companies/units in India demonstrating the highest level of commitment to Environmental Management across different sectors.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amgen/Pfizer's Enbrel is the leading tumor necrosis factor -alpha inhibitor prescribed in newly diagnosed rheumatoid arthritis patients, outpacing Abbott's Humira in the first three lines of treatment.
› Verified 2 days ago
Entity Name | Women's Health Associates, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942421094 PECOS PAC ID: 8224000229 Enrollment ID: O20040810001106 |
News Archive
Guidant Corporation has announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) will review Guidant's submission to expand user labeling, including indications, for its cardiac resynchronization therapy defibrillators
Developing psychiatric medications is a long and complex process. Candidate drugs are evaluated and assessed based on their effects on the behavior of animals, usually rats or mice. Each class of drugs, from antidepressants to antipsychotics, is tested differently - often in a labor-intensive process that leaves plenty of room for human error. And there is a growing consensus that current procedures fail to effectively produce new medications.
Nipro Diagnostics, Inc. today announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalance and TRUEtrack Blood Glucose Meters distributed both in the United States and outside the United States.
Two manufacturing facilities of Glenmark located in Goa and Nashik bagged the prestigious 'Greentech Environment Gold Award - 2015' for Excellence in Environment Management at a ceremony in Kolkata recently. Greentech Environment Awards are presented ever year to companies/units in India demonstrating the highest level of commitment to Environmental Management across different sectors.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amgen/Pfizer's Enbrel is the leading tumor necrosis factor -alpha inhibitor prescribed in newly diagnosed rheumatoid arthritis patients, outpacing Abbott's Humira in the first three lines of treatment.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mishal Shoaib Khan, MD 27 Hospital Avenue, Suite 303, Danbury, CT 06810 Ph: (203) 798-0500 | Dr Mishal Shoaib Khan, MD 27 Hospital Avenue, Suite 303, Danbury, CT 06810 Ph: (203) 798-0500 |
News Archive
Guidant Corporation has announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) will review Guidant's submission to expand user labeling, including indications, for its cardiac resynchronization therapy defibrillators
Developing psychiatric medications is a long and complex process. Candidate drugs are evaluated and assessed based on their effects on the behavior of animals, usually rats or mice. Each class of drugs, from antidepressants to antipsychotics, is tested differently - often in a labor-intensive process that leaves plenty of room for human error. And there is a growing consensus that current procedures fail to effectively produce new medications.
Nipro Diagnostics, Inc. today announced it is initiating a voluntary recall and replacement of a limited number of TRUEbalance and TRUEtrack Blood Glucose Meters distributed both in the United States and outside the United States.
Two manufacturing facilities of Glenmark located in Goa and Nashik bagged the prestigious 'Greentech Environment Gold Award - 2015' for Excellence in Environment Management at a ceremony in Kolkata recently. Greentech Environment Awards are presented ever year to companies/units in India demonstrating the highest level of commitment to Environmental Management across different sectors.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amgen/Pfizer's Enbrel is the leading tumor necrosis factor -alpha inhibitor prescribed in newly diagnosed rheumatoid arthritis patients, outpacing Abbott's Humira in the first three lines of treatment.
› Verified 2 days ago
Dr. Nicole Christine Brzozowski, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-6378 | |
Richard S Ruben, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 90 Locust Avenue, Danbury, CT 06810 Phone: 203-792-5005 Fax: 203-791-9899 | |
Yelena Paranyuk, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 90 Locust Ave, Danbury, CT 06810 Phone: 203-792-5005 Fax: 203-791-9899 | |
Patrice S Gillotti, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 90 Locust Avenue, Danbury, CT 06810 Phone: 203-792-5005 Fax: 203-791-9899 | |
Jacqueline Early, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave Dept Of, Danbury, CT 06810 Phone: 203-739-6378 | |
Pamela J Swift, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 103 Newtown Road, Danbury, CT 06810 Phone: 203-730-8789 Fax: 203-743-5229 | |
Dr. Patricia E Whitcombe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 27 Hospital Ave, Suite 303, Danbury, CT 06810 Phone: 203-798-0500 Fax: 203-798-0881 |